◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › AEMD

Aethlon Medical, Inc. (AEMD) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Medical Devices · DATA UPDATED 2026-07-26

Aethlon Medical, Inc. (AEMD) operates in the Medical Devices industry and is headquartered in San Diego, United States with about 9 employees. Its market capitalization is roughly $2 million. In the fiscal year ended 2026-03-31, AEMD reported $0M in revenue and ($7M) in net income.

Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States.

Interactive charts & full statements →

AEMD Revenue & Earnings History — Annual Income Statement

Income statement2026-03-312025-03-312024-03-312023-03-312022-03-31
Total Revenue$0M$0M$0M$1M
Operating Income (EBIT)($7M)($9M)($13M)($12M)
Net Income($7M)($13M)($12M)($12M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

AEMD Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total Revenue$0M$0M$0M$0M$0M
Operating Income (EBIT)($2M)($2M)($2M)($2M)($2M)
Net Income($2M)($2M)($2M)($2M)($6M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

AEMD Free Cash Flow History

AEMD Balance Sheet History

Balance sheet2026-03-312025-03-312024-03-312023-03-312022-03-31
Total Assets$6M$7M$8M$18M
Total Liabilities$1M$2M$2M$2M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive AEMD viewer.

Other Companies in Medical Devices

← AEMAll stocksAENT →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.